Affordable Access

deepdyve-link deepdyve-link
Publisher Website

Increasing use of radioiodine in young people with thyrotoxicosis in Great Britain.

Authors
Type
Published Article
Journal
European Journal of Endocrinology
1479-683X
Publisher
Bioscientifica
Publication Date
Volume
167
Issue
5
Pages
715–718
Identifiers
DOI: 10.1530/EJE-12-0542
PMID: 22956555
Source
Medline
License
Unknown

Abstract

A rising proportion of patients with thyrotoxicosis receiving RI are in those <21 years. This is largely due to an increase in the number of young people treated with a reduction in the minimum age at RI administration. We suspect that European clinicians are becoming more comfortable with RI treatment in young people with thyrotoxicosis, although a changing incidence is a potential contributing factor.

Statistics

Seen <100 times